According to Latest Research, the global market for Infliximab Biosimilar should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Infliximab Biosimilar market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Infliximab Biosimilar market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, CT-P13/infliximab-dyyb segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Crohn's Disease has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Infliximab Biosimilar include Napp Pharmaceuticals Group, Janssen Biotech, Alvogen, Merck, Celltrion, Pfizer(Ac Hospira) and Nippon Kayaku, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Infliximab Biosimilar. Report Highlights:

(1) Global Infliximab Biosimilar market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2023 to 2030.

(2) Global Infliximab Biosimilar market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(3) China Infliximab Biosimilar market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(4) Global Infliximab Biosimilar segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Infliximab Biosimilar segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Infliximab Biosimilar, capacity, production and trends.

(7) Infliximab Biosimilar industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

CT-P13/infliximab-dyyb

Remsima

Inflectra

Market segment by application, can be divided into

Crohn's Disease

Rheumatoid Arthritis

Ulcerative Colitis

Ankylosing Spondylitis

Plaque Psoriasis

Others

Market segment by players, this report covers

Napp Pharmaceuticals Group

Janssen Biotech

Alvogen

Merck

Celltrion

Pfizer(Ac Hospira)

Nippon Kayaku

1 Market Overview

1.1 Infliximab Biosimilar Definition

1.2 Global Infliximab Biosimilar Market Size and Forecast

1.2.1 By Revenue, Global Infliximab Biosimilar Market Size, 2019-2030

1.2.2 By Sales Volume, Global Infliximab Biosimilar Market Size, 2019-2030

1.2.3 Global Infliximab Biosimilar Price Trend, 2019-2030

1.3 China Infliximab Biosimilar Market Size and Forecast

1.3.1 By Revenue, China Infliximab Biosimilar Market Size, 2019-2030

1.3.2 By Sales Volume, China Infliximab Biosimilar Market Size, 2019-2030

1.3.3 China Infliximab Biosimilar Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Infliximab Biosimilar Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Infliximab Biosimilar Share in Global Market, 2019-2030

1.4.3 Infliximab Biosimilar Market Size: China VS Global, 2019-2030

1.5 Infliximab Biosimilar Market Dynamics

1.5.1 Infliximab Biosimilar Market Drivers

1.5.2 Infliximab Biosimilar Market Restraints

1.5.3 Infliximab Biosimilar Industry Trends

1.5.4 Infliximab Biosimilar Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Infliximab Biosimilar Revenue by Company, 2019-2023

2.2 Global Infliximab Biosimilar Sales Volume by Company, 2019-2023

2.3 Global Infliximab Biosimilar Price by Company, 2019-2023

2.4 Global Infliximab Biosimilar Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Infliximab Biosimilar Concentration Ratio

2.6 Global Infliximab Biosimilar Mergers & Acquisitions, Expansion Plans

2.7 Global Infliximab Biosimilar Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Infliximab Biosimilar Revenue by Company, 2019-2023

3.2 China Infliximab Biosimilar Sales Volume by Company, 2019-2023

3.3 China Infliximab Biosimilar Infliximab Biosimilar Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Infliximab Biosimilar Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)

3.5 Chinese Local Players, Infliximab Biosimilar Domestic VS Export

3.6 China Market, Infliximab Biosimilar Import & Export

3.6.1 China Market, Infliximab Biosimilar Import & Export, 2019-2030

3.6.2 China Infliximab Biosimilar Import & Export Trends

3.6.3 Main Sources of China Infliximab Biosimilar Import

3.6.4 Export Destination of China Infliximab Biosimilar

4 Infliximab Biosimilar Production by Region

4.1 Global Infliximab Biosimilar Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Infliximab Biosimilar Manufacturers

4.3 Global Major Manufacturers, Infliximab Biosimilar Capacity Expansion and Future Plans

4.4 Global Infliximab Biosimilar Capacity by Region

4.5 Global Infliximab Biosimilar Production by Region

4.5.1 Global Infliximab Biosimilar Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Infliximab Biosimilar Production by Region, 2019-2023

4.5.3 Global Infliximab Biosimilar Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Infliximab Biosimilar Industry Chain

5.2 Infliximab Biosimilar Upstream Analysis

5.2.1 Infliximab Biosimilar Core Raw Materials

5.2.2 Main Manufacturers of Infliximab Biosimilar Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Infliximab Biosimilar Production Mode

5.6 Infliximab Biosimilar Procurement Model

5.7 Infliximab Biosimilar Industry Sales Model and Sales Channels

5.7.1 Infliximab Biosimilar Sales Model

5.7.2 Infliximab Biosimilar Typical Distributors

6 Sights by Type

6.1 Infliximab Biosimilar Classification

6.1.1 CT-P13/infliximab-dyyb

6.1.2 Remsima

6.1.3 Inflectra

6.2 By Type, Global Infliximab Biosimilar Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Infliximab Biosimilar Revenue, 2019-2030

6.4 By Type, Global Infliximab Biosimilar Sales Volume, 2019-2030

6.5 By Type, Global Infliximab Biosimilar Price, 2019-2030

7 Sights by Application

7.1 Infliximab Biosimilar Segment by Application

7.1.1 Crohn's Disease

7.1.2 Rheumatoid Arthritis

7.1.3 Ulcerative Colitis

7.1.4 Ankylosing Spondylitis

7.1.5 Plaque Psoriasis

7.1.6 Others

7.2 By Application, Global Infliximab Biosimilar Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Infliximab Biosimilar Revenue, 2019-2030

7.4 By Application, Global Infliximab Biosimilar Sales Volume, 2019-2030

7.5 By Application, Global Infliximab Biosimilar Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Infliximab Biosimilar Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Infliximab Biosimilar Revenue, 2019-2030

8.3 By Region, Global Infliximab Biosimilar Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Infliximab Biosimilar Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Infliximab Biosimilar Market Size Market Share

8.5 Europe

8.5.1 Europe Infliximab Biosimilar Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Infliximab Biosimilar Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Infliximab Biosimilar Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Infliximab Biosimilar Market Size Market Share

8.7 South America

8.7.1 South America Infliximab Biosimilar Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Infliximab Biosimilar Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Infliximab Biosimilar Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Infliximab Biosimilar Revenue, 2019-2030

9.3 By Country, Global Infliximab Biosimilar Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Infliximab Biosimilar Market Size, 2019-2030

9.4.2 By Company, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023

9.4.3 By Type, U.S. Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Infliximab Biosimilar Market Size, 2019-2030

9.5.2 By Company, Europe Infliximab Biosimilar Sales Volume Market Share, 2023

9.5.3 By Type, Europe Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Infliximab Biosimilar Market Size, 2019-2030

9.6.2 By Company, China Infliximab Biosimilar Sales Volume Market Share, 2023

9.6.3 By Type, China Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Infliximab Biosimilar Market Size, 2019-2030

9.7.2 By Company, Japan Infliximab Biosimilar Sales Volume Market Share, 2023

9.7.3 By Type, Japan Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Infliximab Biosimilar Market Size, 2019-2030

9.8.2 By Company, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023

9.8.3 By Type, South Korea Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Infliximab Biosimilar Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Infliximab Biosimilar Market Size, 2019-2030

9.10.2 By Company, India Infliximab Biosimilar Sales Volume Market Share, 2023

9.10.3 By Type, India Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Infliximab Biosimilar Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Napp Pharmaceuticals Group

10.1.1 Napp Pharmaceuticals Group Company Information, Head Office, Market Area and Industry Position

10.1.2 Napp Pharmaceuticals Group Infliximab Biosimilar Models, Specifications and Application

10.1.3 Napp Pharmaceuticals Group Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.1.4 Napp Pharmaceuticals Group Company Profile and Main Business

10.1.5 Napp Pharmaceuticals Group Recent Developments

10.2 Janssen Biotech

10.2.1 Janssen Biotech Company Information, Head Office, Market Area and Industry Position

10.2.2 Janssen Biotech Infliximab Biosimilar Models, Specifications and Application

10.2.3 Janssen Biotech Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.2.4 Janssen Biotech Company Profile and Main Business

10.2.5 Janssen Biotech Recent Developments

10.3 Alvogen

10.3.1 Alvogen Company Information, Head Office, Market Area and Industry Position

10.3.2 Alvogen Infliximab Biosimilar Models, Specifications and Application

10.3.3 Alvogen Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.3.4 Alvogen Company Profile and Main Business

10.3.5 Alvogen Recent Developments

10.4 Merck

10.4.1 Merck Company Information, Head Office, Market Area and Industry Position

10.4.2 Merck Infliximab Biosimilar Models, Specifications and Application

10.4.3 Merck Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.4.4 Merck Company Profile and Main Business

10.4.5 Merck Recent Developments

10.5 Celltrion

10.5.1 Celltrion Company Information, Head Office, Market Area and Industry Position

10.5.2 Celltrion Infliximab Biosimilar Models, Specifications and Application

10.5.3 Celltrion Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.5.4 Celltrion Company Profile and Main Business

10.5.5 Celltrion Recent Developments

10.6 Pfizer(Ac Hospira)

10.6.1 Pfizer(Ac Hospira) Company Information, Head Office, Market Area and Industry Position

10.6.2 Pfizer(Ac Hospira) Infliximab Biosimilar Models, Specifications and Application

10.6.3 Pfizer(Ac Hospira) Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.6.4 Pfizer(Ac Hospira) Company Profile and Main Business

10.6.5 Pfizer(Ac Hospira) Recent Developments

10.7 Nippon Kayaku

10.7.1 Nippon Kayaku Company Information, Head Office, Market Area and Industry Position

10.7.2 Nippon Kayaku Infliximab Biosimilar Models, Specifications and Application

10.7.3 Nippon Kayaku Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.7.4 Nippon Kayaku Company Profile and Main Business

10.7.5 Nippon Kayaku Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Infliximab Biosimilar Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Infliximab Biosimilar Market Restraints

Table 3. Infliximab Biosimilar Market Trends

Table 4. Infliximab Biosimilar Industry Policy

Table 5. Global Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million

Table 6. Global Infliximab Biosimilar Revenue Market Share by Company, 2019-2023

Table 7. Global Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023

Table 9. Global Infliximab Biosimilar Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Infliximab Biosimilar Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Infliximab Biosimilar Mergers & Acquisitions, Expansion Plans

Table 12. Global Infliximab Biosimilar Manufacturers Product Type

Table 13. China Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million

Table 14. China Infliximab Biosimilar Revenue Market Share by Company, 2019-2023

Table 15. China Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Infliximab Biosimilar Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Infliximab Biosimilar Import & Export Trends

Table 19. Main Sources of China Infliximab Biosimilar Import

Table 20. Export Destination of China Infliximab Biosimilar

Table 21. Global Headquarters and Manufacturing Base of Infliximab Biosimilar Manufacturers

Table 22. Global Major Manufacturers, Infliximab Biosimilar Capacity Expansion and Future Plans

Table 23. Global Infliximab Biosimilar Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Infliximab Biosimilar Production by Region, 2019-2023, (K Units)

Table 25. Global Infliximab Biosimilar Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Infliximab Biosimilar Upstream (Raw Materials)

Table 27. Global Infliximab Biosimilar Typical Customers

Table 28. Infliximab Biosimilar Typical Distributors

Table 29. By Type, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Infliximab Biosimilar Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Infliximab Biosimilar Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Table 37. By Country, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Table 39. Napp Pharmaceuticals Group Company Information, Head Office, Market Area and Industry Position

Table 40. Napp Pharmaceuticals Group Infliximab Biosimilar Models, Specifications and Application

Table 41. Napp Pharmaceuticals Group Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. Napp Pharmaceuticals Group Company Profile and Main Business

Table 43. Napp Pharmaceuticals Group Recent Developments

Table 44. Janssen Biotech Company Information, Head Office, Market Area and Industry Position

Table 45. Janssen Biotech Infliximab Biosimilar Models, Specifications and Application

Table 46. Janssen Biotech Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Janssen Biotech Company Profile and Main Business

Table 48. Janssen Biotech Recent Developments

Table 49. Alvogen Company Information, Head Office, Market Area and Industry Position

Table 50. Alvogen Infliximab Biosimilar Models, Specifications and Application

Table 51. Alvogen Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Alvogen Company Profile and Main Business

Table 53. Alvogen Recent Developments

Table 54. Merck Company Information, Head Office, Market Area and Industry Position

Table 55. Merck Infliximab Biosimilar Models, Specifications and Application

Table 56. Merck Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Merck Company Profile and Main Business

Table 58. Merck Recent Developments

Table 59. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 60. Celltrion Infliximab Biosimilar Models, Specifications and Application

Table 61. Celltrion Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Celltrion Company Profile and Main Business

Table 63. Celltrion Recent Developments

Table 64. Pfizer(Ac Hospira) Company Information, Head Office, Market Area and Industry Position

Table 65. Pfizer(Ac Hospira) Infliximab Biosimilar Models, Specifications and Application

Table 66. Pfizer(Ac Hospira) Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Pfizer(Ac Hospira) Company Profile and Main Business

Table 68. Pfizer(Ac Hospira) Recent Developments

Table 69. Nippon Kayaku Company Information, Head Office, Market Area and Industry Position

Table 70. Nippon Kayaku Infliximab Biosimilar Models, Specifications and Application

Table 71. Nippon Kayaku Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. Nippon Kayaku Company Profile and Main Business

Table 73. Nippon Kayaku Recent Developments

List of Figure

Figure 1. Infliximab Biosimilar Picture

Figure 2. By Revenue, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Infliximab Biosimilar Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Infliximab Biosimilar Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Infliximab Biosimilar Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Infliximab Biosimilar Share of Global Market, 2019-2030

Figure 10. Global Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Infliximab Biosimilar Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Infliximab Biosimilar Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Infliximab Biosimilar Domestic VS Export, 2023

Figure 16. Global Infliximab Biosimilar Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Infliximab Biosimilar Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Infliximab Biosimilar Production Market Share & Forecast by Region, 2019-2030

Figure 19. Infliximab Biosimilar Industry Chain

Figure 20. Infliximab Biosimilar Procurement Model

Figure 21. Infliximab Biosimilar Sales Model

Figure 22. Infliximab Biosimilar Sales Channels, Direct Sales and Distribution

Figure 23. CT-P13/infliximab-dyyb

Figure 24. Remsima

Figure 25. Inflectra

Figure 26. By Type, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 28. By Type, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)

Figure 31. Crohn's Disease

Figure 32. Rheumatoid Arthritis

Figure 33. Ulcerative Colitis

Figure 34. Ankylosing Spondylitis

Figure 35. Plaque Psoriasis

Figure 36. Others

Figure 37. By Application, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million

Figure 38. By Application, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 39. By Application, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 40. By Application, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 41. By Application, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)

Figure 42. By Region, Global Infliximab Biosimilar Revenue Market Share, 2019-2030

Figure 43. By Region, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030

Figure 44. North America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, North America Infliximab Biosimilar Revenue Market Share, 2023

Figure 46. Europe Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, Europe Infliximab Biosimilar Revenue Market Share, 2023

Figure 48. Asia Pacific Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country/Region, Asia Pacific Infliximab Biosimilar Revenue Market Share, 2023

Figure 50. South America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. By Country, South America Infliximab Biosimilar Revenue Market Share, 2023

Figure 52. Middle East & Africa Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million

Figure 53. U.S. Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, U.S. Infliximab Biosimilar Market Share, 2023

Figure 55. By Type, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 57. Europe Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, Europe Infliximab Biosimilar Market Share, 2023

Figure 59. By Type, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 61. China Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, China Infliximab Biosimilar Market Share, 2023

Figure 63. By Type, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 65. Japan Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, Japan Infliximab Biosimilar Market Share, 2023

Figure 67. By Type, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 69. South Korea Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, South Korea Infliximab Biosimilar Market Share, 2023

Figure 71. By Type, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 73. Southeast Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, Southeast Asia Infliximab Biosimilar Market Share, 2023

Figure 75. By Type, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 77. India Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, India Infliximab Biosimilar Market Share, 2023

Figure 79. By Type, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 81. Middle East & Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)

Figure 82. By Company, Middle East & Asia Infliximab Biosimilar Market Share, 2023

Figure 83. By Type, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 84. By Application, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030

Figure 85. Research Methodology

Figure 86. Breakdown of Primary Interviews

Figure 87. Bottom-up Approaches

Figure 88. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)